Clinical trials appendix Q1 2018 Results update

www.astrazeneca.com

Movement since Q4 2017 update New to Phase I New to Phase II New to Pivotal Study New to Registration NMEs AZD9977 MCR CV disease Calquence+ AZD6738 BTK inhibitor + ATR inhibitor haematologicalmalignancies

  2017, Update, Clinical, Appendix, Trail, Results, 2017 update, Clinical trials appendix, Results update